BrainsWay to Report First Quarter 2025 Financial Results on May 13, 2025
BrainsWay, a global leader in noninvasive neurostimulation treatments for mental health disorders, has scheduled its first quarter 2025 financial results announcement for May 13, 2025, before U.S. markets open.
The company will host a conference call and webcast at 8:30 AM Eastern Time to discuss financial results and business operations. Investors can access the call through multiple channels:
- U.S. participants: 1-877-300-8521
- International callers: 1-412-317-6026
- Israel participants: 1-80-921-2373
The conference call will be available for 30-day replay on BrainsWay's investor relations website. Participants are advised to register at least 10 minutes before the call through https://investors.brainsway.com/events-and-presentations/event-calendar.
BrainsWay, leader mondiale nei trattamenti di neurostimolazione non invasiva per disturbi della salute mentale, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 13 maggio 2025, prima dell'apertura dei mercati statunitensi.
L'azienda terrà una conference call e una trasmissione web alle 8:30 AM ora Eastern per discutere i risultati finanziari e le operazioni aziendali. Gli investitori potranno accedere alla chiamata tramite diversi canali:
- Partecipanti dagli Stati Uniti: 1-877-300-8521
- Chiamanti internazionali: 1-412-317-6026
- Partecipanti in Israele: 1-80-921-2373
La conference call sarà disponibile per la replica di 30 giorni sul sito web delle relazioni con gli investitori di BrainsWay. Si consiglia ai partecipanti di registrarsi almeno 10 minuti prima della chiamata tramite https://investors.brainsway.com/events-and-presentations/event-calendar.
BrainsWay, líder mundial en tratamientos de neuroestimulación no invasiva para trastornos de salud mental, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 13 de mayo de 2025, antes de la apertura de los mercados en EE.UU.
La compañía realizará una llamada conferencia y webcast a las 8:30 AM hora del Este para discutir los resultados financieros y las operaciones comerciales. Los inversores podrán acceder a la llamada a través de varios canales:
- Participantes en EE.UU.: 1-877-300-8521
- Llamadas internacionales: 1-412-317-6026
- Participantes en Israel: 1-80-921-2373
La llamada conferencia estará disponible para repetición durante 30 días en el sitio web de relaciones con inversores de BrainsWay. Se recomienda a los participantes registrarse al menos 10 minutos antes de la llamada en https://investors.brainsway.com/events-and-presentations/event-calendar.
BrainsWay는 정신 건강 장애를 위한 비침습적 신경자극 치료 분야의 글로벌 선두주자로, 2025년 1분기 재무 실적 발표를 2025년 5월 13일 미국 시장 개장 전에 예정했습니다.
회사는 재무 실적 및 사업 운영에 대해 논의하기 위해 동부 표준시 기준 오전 8시 30분에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 투자자들은 다음 채널을 통해 통화에 접속할 수 있습니다:
- 미국 참가자: 1-877-300-8521
- 국제 전화: 1-412-317-6026
- 이스라엘 참가자: 1-80-921-2373
컨퍼런스 콜은 BrainsWay 투자자 관계 웹사이트에서 30일간 다시 듣기가 가능하며, 참가자는 통화 10분 전까지 https://investors.brainsway.com/events-and-presentations/event-calendar 에서 등록할 것을 권장합니다.
BrainsWay, leader mondial des traitements de neurostimulation non invasive pour les troubles de santé mentale, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 13 mai 2025, avant l'ouverture des marchés américains.
L'entreprise tiendra une conférence téléphonique et une webdiffusion à 8h30, heure de l'Est pour discuter des résultats financiers et des opérations commerciales. Les investisseurs pourront accéder à l'appel via plusieurs canaux :
- Participants aux États-Unis : 1-877-300-8521
- Appels internationaux : 1-412-317-6026
- Participants en Israël : 1-80-921-2373
La conférence téléphonique sera disponible en relecture pendant 30 jours sur le site des relations investisseurs de BrainsWay. Il est conseillé aux participants de s'inscrire au moins 10 minutes avant l'appel via https://investors.brainsway.com/events-and-presentations/event-calendar.
BrainsWay, ein weltweit führendes Unternehmen für nicht-invasive Neurostimulationsbehandlungen bei psychischen Erkrankungen, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 13. Mai 2025, vor Öffnung der US-Märkte, geplant.
Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Finanzergebnisse und Geschäftsaktivitäten zu besprechen. Investoren können über verschiedene Kanäle an der Telefonkonferenz teilnehmen:
- Teilnehmer aus den USA: 1-877-300-8521
- Internationale Anrufer: 1-412-317-6026
- Teilnehmer aus Israel: 1-80-921-2373
Die Telefonkonferenz wird auf der Investor-Relations-Webseite von BrainsWay für eine 30-tägige Wiedergabe verfügbar sein. Teilnehmer wird empfohlen, sich mindestens 10 Minuten vor Beginn der Konferenz unter https://investors.brainsway.com/events-and-presentations/event-calendar zu registrieren.
- Global leader position in noninvasive neurostimulation treatments for mental health disorders
- Listed on both NASDAQ and TASE exchanges, providing broader market access
- None.
BURLINGTON, Mass. and JERUSALEM, April 29, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its first quarter 2025 financial results, as well as operational highlights, before the open of the U.S. financial markets on Tuesday, May 13, 2025. The Company will host a conference call and webcast at 8:30 AM Eastern Time the same day to discuss the results and provide an update on business operations.
Conference Call Dial-In & Webcast Information
| Date: | Tuesday, May 13, 2025 |
| Time: | 8:30 AM Eastern Time |
| United States: | 1-877-300-8521 |
| International: | 1-412-317-6026 |
| Israel: | 1-80-921-2373 |
| Conference ID: | 10198731 |
| Webcast: | Link |
The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Company’s website at least 10 minutes ahead of the conference call to register.
About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in Israel and the U.S., BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
Contacts:
BrainsWay:
Ido Marom
Chief Financial Officer
Ido.Marom@BrainsWay.com
Investors:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com
FAQ
When will BrainsWay (BWAY) report Q1 2025 earnings?
How can investors join BrainsWay's Q1 2025 earnings call?
What is the international dial-in number for BWAY's Q1 2025 earnings call?
How long will BrainsWay's Q1 2025 earnings call replay be available?
What information will be covered in BrainsWay's Q1 2025 earnings report?
